Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × marimastat × Clear all

NCT00003011 2020-04-03

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase 3 Completed

Lung Neoplasms, Small Cell Lung Carcinoma